These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 19759858)
1. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus. Liu MF; Weng CT; Weng MY J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858 [TBL] [Abstract][Full Text] [Related]
2. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091 [TBL] [Abstract][Full Text] [Related]
3. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915 [TBL] [Abstract][Full Text] [Related]
4. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells. Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595 [TBL] [Abstract][Full Text] [Related]
5. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376 [TBL] [Abstract][Full Text] [Related]
6. Cryopreservation decreases receptor PD-1 and ligand PD-L1 coinhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes. Campbell DE; Tustin NB; Riedel E; Tustin R; Taylor J; Murray J; Douglas SD Clin Vaccine Immunol; 2009 Nov; 16(11):1648-53. PubMed ID: 19726615 [TBL] [Abstract][Full Text] [Related]
8. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684 [TBL] [Abstract][Full Text] [Related]
9. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19 Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542 [TBL] [Abstract][Full Text] [Related]
10. Modulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Hashimoto N; Shimoda S; Kawanaka H; Tsuneyama K; Uehara H; Akahoshi T; Kinjo N; Taketomi A; Shirabe K; Akashi K; Lleo A; Ansari AA; Gershwin ME; Maehara Y Clin Exp Immunol; 2011 Aug; 165(2):243-50. PubMed ID: 21615390 [TBL] [Abstract][Full Text] [Related]
11. [The proportion of CD19 Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256 [TBL] [Abstract][Full Text] [Related]
12. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930 [TBL] [Abstract][Full Text] [Related]
13. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338 [TBL] [Abstract][Full Text] [Related]
14. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus. Ohshima M; Kanda H; Kubo K; Yonezumi-Hayashi A; Tateishi S; Yamamoto K Lupus; 2013 Jan; 22(1):44-51. PubMed ID: 23087259 [TBL] [Abstract][Full Text] [Related]
15. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337 [TBL] [Abstract][Full Text] [Related]
16. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Ghiotto M; Gauthier L; Serriari N; Pastor S; Truneh A; Nunès JA; Olive D Int Immunol; 2010 Aug; 22(8):651-60. PubMed ID: 20587542 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Kim JR; Mathew SO; Patel RK; Pertusi RM; Mathew PA Clin Exp Immunol; 2010 Jun; 160(3):348-58. PubMed ID: 20345977 [TBL] [Abstract][Full Text] [Related]
18. [Increased expressions of programmed death 1 (PD-1) and its ligands in peripheral CD3(+) T cells and CD19(+) B cells in patients with hepatocellular carcinoma]. Liu W; Chai L; Liang J; Lu Z; Yang S Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1243-7. PubMed ID: 27609582 [TBL] [Abstract][Full Text] [Related]
19. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions. Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380 [TBL] [Abstract][Full Text] [Related]
20. Abnormal membrane-bound and soluble programmed death ligand 2 (PD-L2) expression in systemic lupus erythematosus is associated with disease activity. Tong M; Fang X; Yang J; Wu P; Guo Y; Sun J Immunol Lett; 2020 Nov; 227():96-101. PubMed ID: 32891685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]